Personalized Neoantigen Vaccines Boost Progress Against Aggressive Cancers
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
The Long, Winding Road of Immunotherapy Research
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
Editors’ Picks, June 2024: Metabolic Imaging, Practice-changing Adagrasib Trial, and More
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
Social Determinants of Health: Treating the Person and the Disease
Bianca Islam, MD, PhD, examines how social determinants of health impact cancer patients and what is being done to...
TIL Therapy: A New Melanoma Treatment 30 Years in the Making
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
Dispelling Myths About Prostate Cancer in Black Communities
A poster at the AACR Annual Meeting 2024 examined a video that increased awareness of prostate cancer.
Finding Ways to Overcome Ovarian Cancer’s Resistance to Immunotherapy
Researchers are exploring new combinations of therapy, disrupting iron accumulation, and turning tumors hot in attempts to make ovarian...
Interfacing with the Future: Artificial Intelligence in Oncology
Researchers discussed AI's impact on the diagnosis and treatment of cancer at the AACR Annual Meeting 2024.